Alkermes Plc (ALKS)
28.34
-0.94
(-3.21%)
USD |
NASDAQ |
Mar 05, 16:00
28.34
0.00 (0.00%)
After-Hours: 17:03
Alkermes Cash from Investing (Quarterly) : 322.35M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Avadel Pharmaceuticals Plc | -8.788M |
| Krystal Biotech, Inc. | 11.16M |
| Assertio Holdings, Inc. | -3.812M |
| Amarin Corp. Plc | -- |
| Amicus Therapeutics, Inc. | -6.494M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 170.07M |
| Cash from Financing (Quarterly) | 10.91M |
| Free Cash Flow | 480.33M |
| Free Cash Flow Per Share (Quarterly) | 1.003 |
| Free Cash Flow to Equity (Quarterly) | 171.69M |
| Free Cash Flow to Firm (Quarterly) | 180.12M |
| Free Cash Flow Yield | 10.04% |